SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $50,000 | +78.6% | 253 | +53.3% | 0.00% | – |
| Q2 2020 | $28,000 | +180.0% | 165 | +26.9% | 0.00% | – |
| Q1 2019 | $10,000 | -87.7% | 130 | -87.6% | 0.00% | -100.0% |
| Q3 2018 | $81,000 | +211.5% | 1,045 | +109.0% | 0.00% | – |
| Q1 2018 | $26,000 | -3.7% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +440.0% | 500 | +278.8% | 0.00% | – |
| Q1 2016 | $5,000 | +25.0% | 132 | +63.0% | 0.00% | – |
| Q4 2015 | $4,000 | +33.3% | 81 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | 0.0% | 81 | +28.6% | 0.00% | – |
| Q2 2015 | $3,000 | -40.0% | 63 | -52.3% | 0.00% | – |
| Q1 2015 | $5,000 | -68.8% | 132 | -64.5% | 0.00% | – |
| Q3 2013 | $16,000 | +23.1% | 372 | -10.8% | 0.00% | – |
| Q2 2013 | $13,000 | -7.1% | 417 | +2.7% | 0.00% | – |
| Q1 2013 | $14,000 | – | 406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |